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Editorial on the Research Topic
Magnetic Resonance Imaging for Radiation Therapy
Since the introduction of magnetic resonance imaging (MRI) to radiation therapy (RT), it has
increasingly been adopted in RT treatment planning for target and organ-at-risk (OAR) definition
due to superior soft tissue contrasts. Recently, the roles of MRI in RT have been advanced
to tumor delineation in a multiparametric format, MRI-based treatment planning and dose
calculation, MRI-guided treatment delivery, and outcome assessment using quantitative imaging
metrics or radiomic features. These advancements are due to the development of dedicated MRI
simulators, integration of MRI scanners with radiation treatment platforms, as well as technical
developments and applications of 4D-MRI, tumor tracking, adaptive planning, and treatment
response evaluation. The advancement of machine learning and artificial intelligence also brings
about tremendous opportunities to transform the application of MRI in RT.
This collection includes 16 articles that cover the following themes:
• Target volume delineation and treatment planning workflow using MRI as the primary
imaging modality
Multiparametric MRI (mp-MRI), a combination of morphologic and functional imaging
modalities, has shown the potential to increase the accuracy of tumor detection, localization,
and characterization of cancer aggression. Integration of mp-MRI techniques into RT offers
enormous opportunities to individualize RT adaptation based upon the individual patient’s
response to treatment.
MR spectroscopy imaging (MRSI) can describe the metabolism of different tissues. However,
the spatial resolution is limited due to the very low concentration of the metabolites in tissues.
Iqbal et al. developed a densely connected U-Net to create super resolution spectroscopic images
by training the T1 weighted images (T1WI) and the low-resolution 1H MR spectroscopic images
together. They showed that the 1H spectra were maintained on retrospective in vivo data.
Lee et al. performed a volumetric and voxel-wise analysis of the dominant intraprostatic
lesions (DIL) defined from T2-weighted imaging (T2WI), diffusion weighted imaging (DWI), and
dynamic contrast enhanced (DCE) imaging respectively. The correlation was further classified
according to tumor location and Gleason grade group. The data suggested that constructing a
Boolean sum volume that incorporated T2WI and apparent diffusion coefficient (ADC) maps
were reasonable for delineating the DIL on mp-MRI. The value of adding information provided
by Ktrans maps remains investigational due to the repeatability and consistency of DCE scans.
The interobserver variability also indicated the need to develop a consensus guideline on DIL
delineation using mp-MRI.
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• Techniques to generate synthetic CT from MRI and the
clinical implementation of MRI only workflow
Substantial interest has developed around generating synthetic
CT (sCT) from MRI in order to use MRI as the only, or primary,
imaging modality in the RT workflow. Different methods have
been introduced to create sCT images using bulk density,
atlas-based, or voxel-based approaches. Deep machine learning
algorithms such as a U-Net or Generative Adversarial Network
can learn image features among different imaging modalities and
have great potentials to generate highly accurate synthetic images.
Choi et al. used a bulk anatomical density approach to develop
a method for patient-specific quality assurance for MRI-only
prostate RT. The three-class model (bone, muscle, and fat)
provided accurate dose calculations for verifying sCT for clinical
use in MRI-only workflows. The model has currently been
implemented as a quality assurancemethod in amulti-center trial
of prostate stereotactic RT that includes an MRI-only study.
Gupta et al. used a 3-channel U-Net trained on aligned MRI
and CT pairs in sagittal planes to generate sCT images. The three
channels represented Hounsfield Unit (HU) ranges of voxels
containing air, soft tissue, and bone, respectively. The improved
soft tissue contrast of sCT was proved with low mean absolute
error difference between sCT and actual CT. The improved image
quality was also beneficial for the online image registration with
cone beam CT.
Wang et al. generated sCT from T2WI of nasopharyngeal
carcinoma patients using a 2D U-net algorithm. The deep U-net
with 23 convolutional layers was used to generate sCT. The soft
tissue, nasal bone, bone marrow, and the interface between bones
and soft tissues were carefully evaluated.
Greer et al. described a multi-center study for the
implementation of an MRI-only prostate workflow. A sCT
was created using an atlas-based method from whole pelvic
T2WI scans with an isotropic 1.6mm voxel. A CT scan was
acquired subsequent to MRI only plan approval for patient
specific quality assurance. The 3D gamma was calculated to
evaluate the dose difference between sCT and actual CT, and
gold fiducial marker positions were used to evaluate the image
registration accuracy between sCT and actual CT. All 25 patients
recruited were treated with MRI only workflow.
Mittauer et al. developed an MRI-guided online adaptive
radiotherapy (MRgoART) procedure for palliative care in RT.
The electron density information was incorporated with either
a bulk density override or deformable image registration of
diagnostic CT to the MRI. The plan quality and treatment
delivery efficiency were superior than the conventional method.
Excellent clinical outcomes were observed and were in line with
historical and sampled controls.
• Quantitative analysis of morphological and functional MRI
and their applications in treatment response assessment
Quantitative MRI can reflect tissue characteristics. Imaging
biomarkers from functional MRI can have prognostic
and predictive values for progression free survival, overall
survival, and distant metastases etc. Radiomic features,
which are defined as the post-processing for extraction
of textural information from medical images, can provide
tremendous information to analyze and characterize the
properties of tumor tissues and their physiological and
pathological stages.
In this collection, Cao et al. analyzed MRI-derived gross
tumor volume, blood volume, and ADC from pre-treatment
and mid-treatment, as well as pre-treatment FDG PET metrics
for locally advanced head and neck cancer (HNC) treated with
chemoradiation. The mean ADC values from pre-RT and its
change rate mid-treatment were significant higher and lower
in p16– than p16+ locally advanced HNC tumors, respectively.
These biomarkers had predictive values and compared favorably
with FDG-PET imaging markers.
van Schie et al. analyzed T2 and ADC changes during
treatment and compared patients with and without hormonal
therapy, as the hypoFLAME trial patients received ultra-
hypofractionated prostate radiotherapy with an integrated boost
to the tumor in 5 weekly fractions. Significant ADC changes
were observed in the tumor in patients without hormonal
therapy. Such early response measured with quantitative MRI
holds the potential to predict clinical outcome and guide
treatment adaptation.
Bagher-Ebadian et al. extracted discriminant radiomic
features in the real radiomics-feature space and the latent-
variable space from mp-MRI for prostate cancer. These features
were used to construct an artificial neural network to classify the
DIL from normal prostatic tissues.
Li Z. et al. analyzed pre-treatment T1WI, T2WI, and DWI
for esophageal squamous cell carcinoma patients undergoing
concurrent chemoradiotherapy and identified the ADC texture
features that can be used to predict the overall survival.
Yu et al. also analyzed pre-treatment T1WI, T2WI to identify
tumoral radiomic features that were used to predict patient
eligibility for adaptive radiotherapy in advanced nasopharyngeal
carcinoma (NPC) patients.
Considering post-treatment changes are often highly
heterogeneous, including cellular tumor, fat, necrosis, and cystic
tissue compartments, evaluation of the tumors defined using
pre-treatment images could be limited to predict treatment
response. Blackledge et al. studied 8 commonly used supervised
machine-learning algorithms for tissue classification of mp-
MRI of soft tissue sarcoma to quantify post-RT changes. Five
out of eight algorithms achieved similar performance. Of
the five methods, the Naïve-Bayes classifier was chosen for
further investigation due to its relatively short training and
prediction times.
• Development of MR-Linac
Recent commercial developments of MRI-guided RT
platforms provide great opportunities for direct imaging
guidance, tumor/OAR tracking during RT, and treatment
adaptation. Two systems have received CE and/or FDA
510 k clearance so far: Unity (Elekta, Sweden) and MRIdian
system (Viewray, USA). The Australian MRI-linac system is
at the research prototype stage and has an inline orientation,
with radiation beam parallel to the main magnetic field.
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Such inline design can help minimize magnetic field
influence on dose deposition. Jelen et al. developed methods
to quantify dosimetric characteristics of the Australian
MRI-linac system.
• Review papers
There are two review papers in this collection. As MRI-guided
RT, including adaptive RT, have advanced in the field, the
community needs to develop protocols on how to make clinical
decisions with funneling MRIgRT data. Kiser et al. discussed the
challenges of interpretability and reproducibility of MRI data, the
complexity of a variety of MR sequences, and the corresponding
impacts on RT workflow, such as synthetic CT generation,
image fusion, dose calculation, and prognostic values using
radiomic features.
Li G. et al. reviewed two 4D-MRI techniques—respiratory-
correlated (RC) and time-resolved (TR) 4D-MRI. The
RC-4DMRI was reconstructed to provide one-breathing-
cycle motion, while the TR-4DMRI provided an adequate
spatiotemporal resolution to assess tumor motion and motion
variation. Both techniques were also discussed in the context of
their clinical applications in radiotherapy.
Benefitting from advanced technologies of synthetic CT
techniques and MR Linacs, the MR-solely RT workflow has
been rapidly evolving and has been clinically implemented
widely. It has potential to improve the therapeutic gains for
certain disease sites through dose escalation with better tumor
delineation and motion management. Randomized clinical
trials have been promoted to investigate the effects of dose
escalation on normal tissue toxicity, quality of life, as well
as overall survival and local control for prostate cancer,
locally advanced pancreatic cancer, etc. As MRI is playing
an increasingly essential role in RT, opportunities arise to
incorporate functional imaging into RT workflow. Considering
the response of the ADC maps to radiation dose and relatively
robust protocol for DWI acquisition, DWI-derived biomarkers
have strong potentials for tumor delineation and response
assessment, as evidenced in a series of articles published in
this collection.
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